A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer

• Authors: Łukasz Dziki , Karolina Przybyłowska , Ireneusz Majsterek , Radzisław Trzciński , Michał Mik , Andrzej Sygut
• Languages of publication: EN

Abstracts

EN

In gastrointestinal malignancies increased expression of matrilysin - MMP-7 - is often observed. Its high level positively correlates with clinical stage of malignancy and is a negative prognostic factor. This suggests a possible relationship between functional polymorphisms of the MMP-7 gene and susceptibility to development of colorectal cancer and an aggressive course of the disease.The aim of the study was to assess the effects of A/G functional polymorphism at -181 site of the MMP-7 gene promoter region on development and progression of colorectal cancer.Material and methods. In total, 184 patients treated surgically for colorectal cancer at the Department of General and Colorectal Surgery of the Medical University in Łódź in the years 2006-2009 and a control group of 205 cancer-free individuals with a negative family history for malignancy have been investigated. Polymorphic variants of the MMP-7 gene promoter region have been analysed using the RFLP-PCR method.Results. A statistically significant difference in distribution of genotypes has been found between the investigated group and the control group, and the OR analysis confirmed a relationship between the A/G [1.67 (1.03-2.72); p= 0.038] and G/G [2.12 (1.34-3.38); p = 0.018] genotypes and an increased risk of colorectal cancer. The risk of lymph node involvement was more than twice higher for the G/G genotype (OR = 2.83 (1.18-6.79); P = 0.017). In addition, the analysis of genotype distribution in patients divided into groups according to the T parameter of the TNM classification revealed a relationship between the G/G genotype and advanced tumour infiltration. No relationship between the investigated A/G polymorphism and the presence of distant metastases has been found.Conclusions. Obtained results indicate a possible relationship between -181 A/G polymorphism of the MMP-7 gene and malignant transformation of colorectal epithelial cells and progression of colorectal cancer. This suggests applicability of this polymorphism as a predisposing factor for the disease and a prognostic factor, which in the future may be useful in the management algorithm for colorectal cancer.

Keywords

EN

A/G polymorphism; MMP-7 gene; colorectal cancer

• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2011
• Volume: 83
• Issue: 11
• Pages: 622-626

Dates

published

1 - 11 - 2011

online

13 - 1 - 2012

Contributors

author

Łukasz Dziki

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Karolina Przybyłowska

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Ireneusz Majsterek

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Radzisław Trzciński

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Michał Mik

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Andrzej Sygut

• Department of General and Colorectal Surgery, Medical University in Łódź

References

• Zhou JH, Zhang B, Kernstine KH et al.: Autoanti-bodies against MMP-7 as anovel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol 2011 Mar 14; 17(10): 1373-78[WoS]
• Koskensalo S, Louhimo J, Nordling S et al.: MMP-7 as aprognostic marker in colorectal cancer. Tumour Biol 2011 Apr; 32(2): 259-64.[Crossref]
• Zhang M, Zhu GY, Gao HY et al.: Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastrin adenocarcinoma. J Surg Oncol 2011 Mar 1; 103(3): 243-47.
• Hulboy DL, Gautam S, Fingleton B et al.: The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncol Rep 2004; 12: 13-17.
• Vargo-Gogola T, Crawford HC, Fingleton B et al.: Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002; 408: 155-61.
• Noe V, Fingleton B, Jacobs K et al.: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001; 114: 111-18.
• Nishizuka I, Ichikawa Y, Ishikawa T et al.: Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo. Cancer Lett 2001; 173: 175-82.
• Chang JH, Javier JA, Chang GY et al.: Functional characterization of neostatins, the MMP-derived, enzymatic cleavage products of type XVIII collagen. FEBS Lett 2005; 579: 3601-06
• Adachi Y, Yamamoto H, Itoh F et al.: Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int J Cancer 2001; 95: 290-94.
• Singh H, Jain M, Mittal B: MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol 2008 Jul; 110(1): 71-75.
• Hughes S, Agbaje O, Bowen RL et al.: Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression. Clin Cancer Res. 2007 Nov 15; 13(22 Pt 1): 6673-80.[WoS]
• Jones JL, Walker RA: Control of matrix metal-loproteinase activity in cancer. J Pathol 1997; 183: 377-79.
• Fridman R, Toth M, Chvyrkova I et al.: Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003; 22(2-3): 153-66.[PubMed][Crossref]
• Yu WH, Woessner JFJ, McNeish JD et al.: CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev 2002; 16: 307-23

Identifiers

DOI

10.2478/v10035-011-0098-1